Skip to main content
logo
Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India flag India · Delayed Price · Currency is INR
2,074.10
+1.20 (0.06%)
Jul 16, 2025, 3:29 PM IST

Caplin Point Laboratories Revenue

In the fiscal year ending March 31, 2025, Caplin Point Laboratories had annual revenue of 19.37B INR with 14.23% growth. Caplin Point Laboratories had revenue of 5.02B in the quarter ending March 31, 2025, with 10.37% growth.

Revenue
19.37B
Revenue Growth
+14.23%
P/S Ratio
8.12
Revenue / Employee
5.69M
Employees
3,406
Market Cap
157.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202519.37B2.41B14.23%
Mar 31, 202416.96B2.28B15.51%
Mar 31, 202314.68B1.97B15.53%
Mar 31, 202212.71B2.09B19.64%
Mar 31, 202110.62B1.98B22.96%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries525.78B
Divi's Laboratories93.60B
Cipla272.67B
Mankind Pharma122.07B
Apollo Hospitals Enterprise217.94B
Zydus Lifesciences232.42B
Aurobindo Pharma317.24B
Glenmark Pharmaceuticals134.35B
Revenue Rankings

Caplin Point Laboratories News

More News